BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37178708)

  • 1. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40-49 years: a modelling study.
    Huntley C; Torr B; Sud A; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet; 2023 Nov; 402 Suppl 1():S54. PubMed ID: 37997097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysis.
    Xia C; Xu Y; Li H; He S; Chen W
    Lancet Reg Health West Pac; 2024 Mar; 44():101012. PubMed ID: 38304718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
    Mavaddat N; Michailidou K; Dennis J; Lush M; Fachal L; Lee A; Tyrer JP; Chen TH; Wang Q; Bolla MK; Yang X; Adank MA; Ahearn T; Aittomäki K; Allen J; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Auer PL; Auvinen P; Barrdahl M; Beane Freeman LE; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Brenner H; Brentnall A; Brock IW; Brooks-Wilson A; Brucker SY; Brüning T; Burwinkel B; Campa D; Carter BD; Castelao JE; Chanock SJ; Chlebowski R; Christiansen H; Clarke CL; Collée JM; Cordina-Duverger E; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dumont M; Durcan L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Försti A; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Gilyazova IR; Glendon G; Goldberg MS; Goldgar DE; González-Neira A; Grenaker Alnæs GI; Grip M; Gronwald J; Grundy A; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hankinson SE; Harkness EF; Hart SN; He W; Hein A; Heyworth J; Hillemanns P; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Jakimovska M; Jakubowska A; Janni W; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kaczmarek K; Kataja V; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Knight JA; Ko YD; Kosma VM; Koutros S; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Lilyquist J; Lindblom A; Lindström S; Lissowska J; Lo WY; Loibl S; Long J; Lubiński J; Lux MP; MacInnis RJ; Maishman T; Makalic E; Maleva Kostovska I; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Martinez ME; Mavroudis D; McLean C; Meindl A; Menon U; Middha P; Miller N; Moreno F; Mulligan AM; Mulot C; Muñoz-Garzon VM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; Offit K; Olson JE; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Peto J; Pinchev M; Plaseska-Karanfilska D; Polley EC; Prentice R; Presneau N; Prokofyeva D; Purrington K; Pylkäs K; Rack B; Radice P; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Robson M; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seynaeve C; Shah M; Sherman ME; Shrubsole MJ; Shu XO; Slager S; Smeets A; Sohn C; Soucy P; Southey MC; Spinelli JJ; Stegmaier C; Stone J; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Truong T; Tzardi M; Ulmer HU; Untch M; Vachon CM; van Veen EM; Vijai J; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett W; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zhang Y; Zheng W; Ziogas A; ; ; ; Dunning AM; Thompson DJ; Chenevix-Trench G; Chang-Claude J; Schmidt MK; Hall P; Milne RL; Pharoah PDP; Antoniou AC; Chatterjee N; Kraft P; García-Closas M; Simard J; Easton DF
    Am J Hum Genet; 2019 Jan; 104(1):21-34. PubMed ID: 30554720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
    Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
    Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
    Thomas M; Sakoda LC; Hoffmeister M; Rosenthal EA; Lee JK; van Duijnhoven FJB; Platz EA; Wu AH; Dampier CH; de la Chapelle A; Wolk A; Joshi AD; Burnett-Hartman A; Gsur A; Lindblom A; Castells A; Win AK; Namjou B; Van Guelpen B; Tangen CM; He Q; Li CI; Schafmayer C; Joshu CE; Ulrich CM; Bishop DT; Buchanan DD; Schaid D; Drew DA; Muller DC; Duggan D; Crosslin DR; Albanes D; Giovannucci EL; Larson E; Qu F; Mentch F; Giles GG; Hakonarson H; Hampel H; Stanaway IB; Figueiredo JC; Huyghe JR; Minnier J; Chang-Claude J; Hampe J; Harley JB; Visvanathan K; Curtis KR; Offit K; Li L; Le Marchand L; Vodickova L; Gunter MJ; Jenkins MA; Slattery ML; Lemire M; Woods MO; Song M; Murphy N; Lindor NM; Dikilitas O; Pharoah PDP; Campbell PT; Newcomb PA; Milne RL; MacInnis RJ; Castellví-Bel S; Ogino S; Berndt SI; Bézieau S; Thibodeau SN; Gallinger SJ; Zaidi SH; Harrison TA; Keku TO; Hudson TJ; Vymetalkova V; Moreno V; Martín V; Arndt V; Wei WQ; Chung W; Su YR; Hayes RB; White E; Vodicka P; Casey G; Gruber SB; Schoen RE; Chan AT; Potter JD; Brenner H; Jarvik GP; Corley DA; Peters U; Hsu L
    Am J Hum Genet; 2020 Sep; 107(3):432-444. PubMed ID: 32758450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank.
    Hu J; Ye Y; Zhou G; Zhao H
    JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38366150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
    Ho WK; Tan MM; Mavaddat N; Tai MC; Mariapun S; Li J; Ho PJ; Dennis J; Tyrer JP; Bolla MK; Michailidou K; Wang Q; Kang D; Choi JY; Jamaris S; Shu XO; Yoon SY; Park SK; Kim SW; Shen CY; Yu JC; Tan EY; Chan PMY; Muir K; Lophatananon A; Wu AH; Stram DO; Matsuo K; Ito H; Chan CW; Ngeow J; Yong WS; Lim SH; Lim GH; Kwong A; Chan TL; Tan SM; Seah J; John EM; Kurian AW; Koh WP; Khor CC; Iwasaki M; Yamaji T; Tan KMV; Tan KTB; Spinelli JJ; Aronson KJ; Hasan SN; Rahmat K; Vijayananthan A; Sim X; Pharoah PDP; Zheng W; Dunning AM; Simard J; van Dam RM; Yip CH; Taib NAM; Hartman M; Easton DF; Teo SH; Antoniou AC
    Nat Commun; 2020 Jul; 11(1):3833. PubMed ID: 32737321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
    Barnes DR; Silvestri V; Leslie G; McGuffog L; Dennis J; Yang X; Adlard J; Agnarsson BA; Ahmed M; Aittomäki K; Andrulis IL; Arason A; Arnold N; Auber B; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Barwell J; Belotti M; Benitez J; Berthet P; Boonen SE; Borg Å; Bozsik A; Brady AF; Brennan P; Brewer C; Brunet J; Bucalo A; Buys SS; Caldés T; Caligo MA; Campbell I; Cassingham H; Christensen LL; Cini G; Claes KBM; ; ; Cook J; Coppa A; Cortesi L; Damante G; Darder E; Davidson R; de la Hoya M; De Leeneer K; de Putter R; Del Valle J; Diez O; Ding YC; Domchek SM; Donaldson A; Eason J; Eeles R; Engel C; Evans DG; Feliubadaló L; Fostira F; Frone M; Frost D; Gallagher D; Gehrig A; Giraud S; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gregory H; Gross E; Hahnen E; Hamann U; Hansen TVO; Hanson H; Hentschel J; Horvath J; ; ; Izatt L; Izquierdo A; James PA; Janavicius R; Jensen UB; Johannsson OT; John EM; Kramer G; Kroeldrup L; Kruse TA; Lautrup C; Lazaro C; Lesueur F; Lopez-Fernández A; Mai PL; Manoukian S; Matrai Z; Matricardi L; Maxwell KN; Mebirouk N; Meindl A; Montagna M; Monteiro AN; Morrison PJ; Muranen TA; Murray A; Nathanson KL; Neuhausen SL; Nevanlinna H; Nguyen-Dumont T; Niederacher D; Olah E; Olopade OI; Palli D; Parsons MT; Pedersen IS; Peissel B; Perez-Segura P; Peterlongo P; Petersen AH; Pinto P; Porteous ME; Pottinger C; Pujana MA; Radice P; Ramser J; Rantala J; Robson M; Rogers MT; Rønlund K; Rump A; Sánchez de Abajo AM; Shah PD; Sharif S; Side LE; Singer CF; Stadler Z; Steele L; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teulé A; Thull DL; Tischkowitz M; Toland AE; Tommasi S; Toss A; Trainer AH; Tripathi V; Valentini V; van Asperen CJ; Venturelli M; Viel A; Vijai J; Walker L; Wang-Gohrke S; Wappenschmidt B; Whaite A; Zanna I; Offit K; Thomassen M; Couch FJ; Schmutzler RK; Simard J; Easton DF; Chenevix-Trench G; Antoniou AC; Ottini L;
    J Natl Cancer Inst; 2022 Jan; 114(1):109-122. PubMed ID: 34320204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations.
    Xin J; Du M; Gu D; Jiang K; Wang M; Jin M; Hu Y; Ben S; Chen S; Shao W; Li S; Chu H; Zhu L; Li C; Chen K; Ding K; Zhang Z; Shen H; Wang M
    Genome Med; 2023 Jan; 15(1):4. PubMed ID: 36694225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer.
    Obón-Santacana M; Díez-Villanueva A; Alonso MH; Ibáñez-Sanz G; Guinó E; López A; Rodríguez-Alonso L; Mata A; García-Rodríguez A; Palomo AG; Molina AJ; Garcia M; Binefa G; Martín V; Moreno V
    BMC Med; 2021 Nov; 19(1):261. PubMed ID: 34743725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
    Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
    Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis.
    Thomas C; Mandrik O; Saunders CL; Thompson D; Whyte S; Griffin S; Usher-Smith JA
    Cancer Prev Res (Phila); 2021 Aug; 14(8):811-822. PubMed ID: 34039685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.